0001053369-20-000001.txt : 20200713 0001053369-20-000001.hdr.sgml : 20200713 20200713124955 ACCESSION NUMBER: 0001053369-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200713 DATE AS OF CHANGE: 20200713 EFFECTIVENESS DATE: 20200713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /NV/ CENTRAL INDEX KEY: 0001053369 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223542636 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-370807 FILM NUMBER: 201024806 BUSINESS ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 BUSINESS PHONE: 2017502646 MAIL ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 FORMER COMPANY: FORMER CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/ DATE OF NAME CHANGE: 19980121 D 1 primary_doc.xml X0708 D LIVE 0001053369 ELITE PHARMACEUTICALS INC /NV/ 165 LUDLOW AVENUE NORTHVALE NJ NEW JERSEY 07647 2017502646 NEVADA ELITE PHARMACEUTICALS INC /DE/ Corporation true Nasrat Hakim 165 Ludlow Avenue Northvale NJ NEW JERSEY 07647 Executive Officer Director Carter Ward 165 Ludlow Avenue Northvale NJ NEW JERSEY 07647 Executive Officer Douglas Plassche 165 Ludlow Avenue Northvale NJ NEW JERSEY 07647 Executive Officer Jeffrey Whitnell 165 Ludlow Avenue Northvale NJ NEW JERSEY 07647 Director Barry Dash 165 Ludlow Avenue Northvale NJ NEW JERSEY 07647 Director Davis Caskey 165 Ludlow Avenue Northvale NJ NEW JERSEY 07647 Director Pharmaceuticals Decline to Disclose 06b false 2020-07-08 true true false 1 26000000 500000 25500000 Amounts include common stock issued and issuable to Lincoln Park Capital as commitment and additional commitment shares under the purchase agreement. false 1 0 0 0 true false ELITE PHARMACEUTICALS INC /NV/ Carter Ward Carter Ward CFO 2020-07-13